Radioiodine remnant ablation (RRA) was developed in the 1960s to “complete a
thyroidectomy” in the initial management of papillary and follicular thyroid cancer. By the …

Abstract 2,512 consecutive patients with papillary thyroid carcinoma (PTC) were managed
during 1940 through 2000 at the Mayo Clinic. During that period, there were two significant …

GENERAL aspects of the diagnosis and management of differentiated thyroid carcinoma
(DTC) have been reviewed recently (1) and guidelines for management proposed (2). Yet …

Background: The risk of recurrence in patients with differentiated thyroid cancer (DTC) can
be estimated based on their response to initial therapy. The aim of this study was to evaluate …

Background Papillary thyroid cancer (PTC) is commonly associated with neck lymph node
metastasis (LNM), and recurrence does occur after radioactive iodine (RAI) ablation therapy …

To identify indications for external radiotherapy (EXT) and radioactive iodine (RAI) in
papillary thyroid carcinoma (PTC), we conducted a retrospective study of local and regional …

Objective Postoperative radioactive iodine (RAI) adjuvant therapy improves the prognosis in
patients with advanced papillary thyroid carcinoma (PTC), although the role of RAI adjuvant …

Background The prognostic influence of lateral neck nodal metastases present at the time of
diagnosis of papillary thyroid cancer (PTC) remains controversial. This study aims to …

Purpose Five percent of patients with differentiated thyroid cancer are diagnosed with
radioiodine refractory relapse in the course of the disease. For isolated or oligometastatic …

The management of papillary thyroid carcinoma continues to evolve. Although the debate
over the extent of thyroidectomy has largely faded, the role of elective neck dissection in the …